Treatment of high-risk T-NHL with autologous or allogeneic stem cell transplantation

被引：0
|
作者：
Busemann, C. [1 ]
Klein, S. [1 ]
Schmidt, C. A. [1 ]
Evert, M. [1 ]
Doelken, G. [1 ]
Krueger, W. H. [1 ]
机构：
[1] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S542 / S543
页数：2
相关论文
共 50 条
  • [1] Treatment of high-risk T-NHL with autologous or allogeneic stem cell transplantation
    Krueger, W. H.
    Busemann, C.
    Klein, S.
    Schmidt, C. A.
    Doelken, G.
    ONKOLOGIE, 2012, 35 : 42 - 42
  • [2] Treatment of High-Risk T-NHL with Stem Cell Transplantation: A Single Center Experience
    Busemann, Christoph
    Klein, Susanne
    Schmidt, Christian Andreas
    Evert, Matthias
    Doelken, Gottfried
    Krueger, William H.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2015, 31 (01) : 14 - 20
  • [3] Treatment of High-Risk T-NHL with Stem Cell Transplantation: A Single Center Experience
    Christoph Busemann
    Susanne Klein
    Christian Andreas Schmidt
    Matthias Evert
    Gottfried Dölken
    William H. Krüger
    Indian Journal of Hematology and Blood Transfusion, 2015, 31 : 14 - 20
  • [4] Autologous (auto) Versus Allogeneic (allo) Hematopoietic Cell Transplantation (HCT) for T-NHL: A CIBMTR Analysis
    Smith, Sonali
    Burns, Linda J.
    van Besien, Koen
    LeRademacher, Jennifer
    He, Wensheng
    Laport, Ginna G.
    Montoto, Silvia
    Maloney, David G.
    Hari, Parameswaran
    BLOOD, 2010, 116 (21) : 303 - 304
  • [5] Allogeneic stem cell transplantation as treatment for relapsed and high-risk peripheral T-cell lymphoma
    O'Leary, Hilary M.
    Savage, Kerry J.
    Toze, Cynthia L.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Abou Mourad, Yasser
    Barnett, Michael J.
    Forrest, Donna L.
    Hogge, Donna E.
    Lavoie, Julye
    Nantel, Stephen H.
    Nevill, Thomas J.
    Shepherd, John D.
    Smith, Clayton
    Sutherland, Heather J.
    Voss, Nicholas
    Brinkmann, Ryan
    Song, Kevin
    BLOOD, 2007, 110 (11) : 893A - 893A
  • [6] Comparison of allogeneic or autologous hematopoietic stem cell transplant for high-risk peripheral T cell lymphomas
    王强力
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (01) : 54 - 55
  • [7] Autologous stem cell transplantation in patients with high-risk plasmacytoma
    Jantunen, E
    Koivunen, E
    Putkonen, M
    Siitonen, T
    Juvonen, E
    Nousiainen, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (05) : 402 - 406
  • [8] Allogeneic Stem Cell Transplantation for High-Risk Neuroblastoma Patients
    Choeyprasert, W.
    Hongeng, S.
    Pakakasama, S.
    Anurathapan, U.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S244 - S245
  • [9] THE IMPORTANCE OF TIMING OF HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH T-CELL LYMPHOMAS (T-NHL)
    Ritter, E. M.
    Zamkoff, K. W.
    Levitan, D. A.
    Hurd, D. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S238 - S238
  • [10] A SUCCESSFUL TREATMENT STRATEGY FOR PATIENTS WITH T-NHL: ALLOGENEIC TRANSPLANTATION AFTER BEAM-ALEMTUZUMAB CONDITIONING
    Gramatzki, M.
    Schade, H.
    Schrauder, A.
    Humpe, A.
    Repp, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 66 - 66
12345